Medicus Pharma
MDCX · NASDAQ
$2.50−$0.12 (−4.58%)TodayMarket closed ·
Prev close $2.62
Who owns MDCX
Largest institutional holders, from their latest 13F filings
| Holder | Shares | % of shares |
|---|---|---|
| Velocity Fund Partners LP | 2.91M | 157.53% |
| 215 Capital Togo PHL Fund I, LP | 2.00M | 108.11% |
| Interchange Capital Partners LLC | 1.59M | 85.78% |
| Hathaway (John) | 800.95K | 43.29% |
| Bokhari (Raza) | 793.17K | 42.87% |
| Melani (Kenneth) | 409.41K | 22.13% |
| Jane Street Capital, L.L.C. | 333.67K | 18.04% |
| XTX Markets LLC | 243.36K | 13.15% |
| Sterling Investment Advisors, Ltd. | 100.00K | 5.41% |
| Brennan (Edward Joseph JR) | 86.50K | 4.68% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of MDCX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Mehmud Faisal | Award | 250.00K | — |
| Mehmud Faisal | Award | 1.47M | $250.74K |
| Brennan Edward J. | Award | 100.00K | — |
| Brennan Edward J. | Award | 588.24K | $100.29K |
| Bonner Carolyn F. | Award | 250.00K | — |
| Bonner Carolyn F. | Award | 1.47M | $250.74K |
| Bokhari Raza | Award | 500.00K | — |
| Bokhari Raza | Award | 2.94M | $501.47K |
| Smith Andrew Alasdair | Award | 125.00K | — |
| Smith Andrew Alasdair | Award | 735.29K | $125.37K |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.69M
- Days to cover
- 1.00
- % of shares outstanding
- 199.30%
- Average daily volume
- 3.92M
- Change since last report
- −26.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.